Atlas Venture Opportunity Fund I, L.P.
CIK 0001759241 Name as filed on the most recent filing
Filed as Atlas Venture Opportunity Fund I, L.P. (25)
133 transaction lines · from 25 filings · filed 2019-06-25 to 2024-03-13 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER Kymera Therapeutics, Inc. 5 filings
- ISSUER Dyne Therapeutics, Inc. 4 filings
- ISSUER Xilio Therapeutics, Inc. 3 filings
- ISSUER Disc Medicine, Inc. 4 filings
- ISSUER Third Harmonic Bio, Inc. 1 filings
- ISSUER Day One Biopharmaceuticals, Inc. 2 filings
- ISSUER Vigil Neuroscience, Inc. 1 filings
- ISSUER Ikena Oncology, Inc. 1 filings
- ISSUER Generation Bio Co. 3 filings
- ISSUER Akero Therapeutics, Inc. 1 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2023-12-14 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 20,429 disposed | 58.27 | 1,190,397.83 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-14 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 180 disposed | 59.74 | 10,753.20 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-14 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 120 disposed | 59.74 | 7,168.80 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-13 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 5,263 disposed | 59.99 | 315,727.37 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-13 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 3,508 disposed | 59.99 | 210,444.92 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-13 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 60 disposed | 60.50 | 3,630.00 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-13 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 40 disposed | 60.50 | 2,420.00 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 31,235 disposed | 59.87 | 1,870,039.45 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 27,924 disposed | 65.10 | 1,817,852.40 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 20,823 disposed | 59.87 | 1,246,673.01 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 18,615 disposed | 65.10 | 1,211,836.50 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 9,901 disposed | 65.77 | 651,188.77 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 6,599 disposed | 65.77 | 434,016.23 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 6,234 disposed | 62.42 | 389,126.28 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 4,155 disposed | 62.42 | 259,355.10 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 1,031 disposed | 63.78 | 65,757.18 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 994 disposed | 62.90 | 62,522.60 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 688 disposed | 63.78 | 43,880.64 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 665 disposed | 62.90 | 41,828.50 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 632 disposed | 60.99 | 38,545.68 | Form 4, filing 0001209191-23-058707 | |
| 2023-12-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 422 disposed | 60.99 | 25,737.78 | Form 4, filing 0001209191-23-058707 | |
| 2023-08-15 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 111,069 disposed | 52.40 | 5,820,015.60 | Form 4, filing 0001209191-23-046110 | |
| 2023-08-15 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 72,931 disposed | 52.40 | 3,821,584.40 | Form 4, filing 0001209191-23-046110 | |
| 2023-08-14 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 98,000 disposed | 53.00 | 5,194,000.00 | Form 4, filing 0001209191-23-046110 | |
| 2023-08-14 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 75,000 disposed | 52.00 | 3,900,000.00 | Form 4, filing 0001209191-23-046110 | |
| 2023-08-14 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 2,000 disposed | 54.80 | 109,600.00 | Form 4, filing 0001209191-23-046110 | |
| 2023-01-12 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 77,128 disposed | 30.29 | 2,336,207.12 | Form 4, filing 0001209191-23-003293 | |
| 2023-01-12 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 21,592 disposed | 30.29 | 654,021.68 | Form 4, filing 0001209191-23-003293 | |
| 2023-01-11 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 21,683 disposed | 29.96 | 649,622.68 | Form 4, filing 0001209191-23-003293 | |
| 2023-01-11 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 6,071 disposed | 29.96 | 181,887.16 | Form 4, filing 0001209191-23-003293 | |
| 2022-12-15 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 2,561 disposed | 30.00 | 76,830.00 | Form 4, filing 0001209191-22-061706 | |
| 2022-12-15 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 717 disposed | 30.00 | 21,510.00 | Form 4, filing 0001209191-22-061706 | |
| 2022-12-14 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 112,819 disposed | 30.28 | 3,416,159.32 | Form 4, filing 0001209191-22-061706 | |
| 2022-12-14 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 101,189 disposed | 31.44 | 3,181,382.16 | Form 4, filing 0001209191-22-061706 | |
| 2022-12-14 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 54,737 disposed | 32.33 | 1,769,647.21 | Form 4, filing 0001209191-22-061706 | |
| 2022-12-14 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 31,584 disposed | 30.28 | 956,363.52 | Form 4, filing 0001209191-22-061706 | |
| 2022-12-14 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 28,329 disposed | 31.44 | 890,663.76 | Form 4, filing 0001209191-22-061706 | |
| 2022-12-14 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 15,324 disposed | 32.33 | 495,424.92 | Form 4, filing 0001209191-22-061706 | |
| 2022-12-14 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 13,997 disposed | 33.34 | 466,659.98 | Form 4, filing 0001209191-22-061706 | |
| 2022-12-14 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 13,335 disposed | 34.02 | 453,656.70 | Form 4, filing 0001209191-22-061706 | |
| 2022-12-14 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 3,919 disposed | 33.34 | 130,659.46 | Form 4, filing 0001209191-22-061706 | |
| 2022-12-14 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 3,733 disposed | 34.02 | 126,996.66 | Form 4, filing 0001209191-22-061706 | |
| 2022-12-12 |
Dyne Therapeutics, Inc. DYN |
P, Open-market purchase | 934,581 acquired | 10.70 | 10,000,016.70 | Form 4, filing 0001209191-22-061243 | |
| 2022-11-03 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 75,312 disposed | 30.00 | 2,259,360.00 | Form 4, filing 0001209191-22-055808 | |
| 2022-11-03 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 21,085 disposed | 30.00 | 632,550.00 | Form 4, filing 0001209191-22-055808 | |
| 2022-11-02 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 96,581 disposed | 30.02 | 2,899,361.62 | Form 4, filing 0001209191-22-055808 | |
| 2022-11-02 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 27,038 disposed | 30.02 | 811,680.76 | Form 4, filing 0001209191-22-055808 | |
| 2022-11-01 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 56,455 disposed | 30.57 | 1,725,829.35 | Form 4, filing 0001209191-22-055142 | |
| 2022-11-01 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 15,804 disposed | 30.57 | 483,128.28 | Form 4, filing 0001209191-22-055142 | |
| 2022-11-01 |
Kymera Therapeutics, Inc. KYMR |
S, Open-market sale | 3,727 disposed | 31.08 | 115,835.16 | Form 4, filing 0001209191-22-055142 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Atlas Venture Opportunity Fund I, L.P., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001759241
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6